Article ID Journal Published Year Pages File Type
2798246 Diabetes Research and Clinical Practice 2008 6 Pages PDF
Abstract

Background/aimsLoss of circadian blood pressure (BP) variation (i.e., lack of nocturnal BP dip by at least 10 mmHg, ‘non-dipping’) is associated with increased mortality rate in subjects with diabetes. We studied whether angiotensin converting enzyme (ACE) insertion/deletion (I/D) gene polymorphism may play a role in 24-h BP rhythm control.MethodsThe study group was 38 normotensive normoalbuminuric type 2 diabetes patients with impaired BP variation, the controls were 51 well-matched type 2 diabetes subjects with normal 24-h BP rhythm. ACE I/D polymorphism, endothelial function and subclinical inflammation parameters (serum endothelin-1, sE-selectin, intercellular and vascular cell adhesion molecules, tumor necrosis factor-α) were assessed.ResultsACE DD genotype was found in 20 (53%), ID genotype in 16 (42%), and II genotype in 2 (5%) study group subjects, while 5 (10%) control subjects had DD genotype, 30 (59%) – ID genotype, and 16 (31%) – II genotype (p < 0.0001). Study group subjects presented with marked endothelial dysfunction.ConclusionImpaired circadian blood pressure variation in normotensive normoalbuminuric type 2 diabetes patients is associated with ACE DD genotype and marked endothelial dysfunction when compared to diabetic subjects with normal blood pressure rhythm.

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Endocrinology
Authors
, , , , , , , ,